Buechel, M., Enserro, D., Burger, R. A., Brady, M. F., Wade, K., Secord, A. A., … Birrer, M. J. (2018). Correlation of imaging and plasma-based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC): A GOG 218 ancillary data analysis. In Journal of Clinical Oncology (Vol. 36, pp. 5507–5507). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.5507

Buechel, Megan, Danielle Enserro, Robert Allen Burger, Mark F. Brady, Katrina Wade, Angeles Alvarez Secord, Andrew B. Nixon, et al. “Correlation of imaging and plasma-based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC): A GOG 218 ancillary data analysis.” In Journal of Clinical Oncology, 36:5507–5507. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.5507.

Buechel M, Enserro D, Burger RA, Brady MF, Wade K, Secord AA, et al. Correlation of imaging and plasma-based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC): A GOG 218 ancillary data analysis. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 5507–5507.

Buechel, Megan, et al. “Correlation of imaging and plasma-based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC): A GOG 218 ancillary data analysis.” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. 5507–5507. Crossref, doi:10.1200/jco.2018.36.15_suppl.5507.

Buechel M, Enserro D, Burger RA, Brady MF, Wade K, Secord AA, Nixon AB, Mirniaharikandehei S, Liu H, Zheng B, Gray H, Tewari KS, O’Malley DM, Mannel RS, Moore KN, Birrer MJ. Correlation of imaging and plasma-based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC): A GOG 218 ancillary data analysis. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 5507–5507.